Adaptive COVID-19 Treatment Trial (ACTT)

From GM-RKB
Jump to navigation Jump to search

An Adaptive COVID-19 Treatment Trial (ACTT) is an Adaptive Clinical Trial that evaluates the safety and efficacy of therapeutic agents in hospitalized adults diagnosed with COVID-19.



References

2020